27.23  -0.08 (-0.29%)		04-25 12:30
Open: 26.85 High: 27.27 Volume: 250,690		Pre. Close: 27.31 Low: 26.4708 Market Cap: 8,272(M)

Short term
Mid term
Targets	6-month :	35.56	1-year :	39.11
Resists	First :	30.44	Second :	33.49
Pivot price	28.34
Supports	First :	25.52	Second :	21.23
MAs	MA(5) :	26.99	MA(20) :	28.99
	MA(100) :	29.53	MA(250) :	29.83
MACD	MACD :	-0.9	Signal :	-0.7
%K %D	K(14,3) :	16.3	D(3) :	10.7
RSI	RSI(14): 36.8
52-week	High :	36.29	Low :	23

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ STVN ] has closed above bottom band by 20.5%. Bollinger Bands are 14.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	28 - 28.13	28.13 - 28.25
Low:	26.81 - 26.97	26.97 - 27.11
Close:	27.06 - 27.31	27.31 - 27.54

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.

Wed, 24 Apr 2024
(STVN) On The My Stocks Page - Stock Traders Daily

Fri, 29 Mar 2024
Here's Why Stevanato Group S.p.A. (STVN) Shares Sold Off in Q4 - Yahoo Finance

Tue, 26 Mar 2024
Latham Advises on Upsized Follow-On Offering of Stevanato Group - Latham & Watkins LLP

Fri, 22 Mar 2024
Stevanato Group sets share price at $26 in public offering - Investing.com

Thu, 21 Mar 2024
Stevanato Group Launches $300M Public Offering - TipRanks.com - TipRanks

Wed, 20 Mar 2024
Stevanato Group Announces Public Offering of Ordinary Shares - Business Wire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	49 (M)
Shares Float	42 (M)
Held by Insiders	2.1 (%)
Held by Institutions	78.4 (%)
Shares Short	2,390 (K)
Shares Short P.Month	2,470 (K)

EPS	0.58
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	4.26
Profit Margin	13.4 %
Operating Margin	19.8 %
Return on Assets (ttm)	6.7 %
Return on Equity (ttm)	13.6 %
Qtrly Rev. Growth	9.8 %
Gross Profit (p.s.)	0
Sales Per Share	22.02
EBITDA (p.s.)	5.45
Qtrly Earnings Growth	-5.6 %
Operating Cash Flow	105 (M)
Levered Free Cash Flow	-405 (M)

PE Ratio	46.04
PEG Ratio	9.5
Price to Book value	6.36
Price to Sales	1.23
Price to Cash Flow	12.77

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.